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Objective: Ultrasound (US) and ultrasound contrast agents (UCAs) provide a way to noninvasively induce targeted
angiogenesis. However, there exists a lack of understanding regarding the mechanisms of this process that has
impeded progress. This study sought to characterize the angiogenic response, by both exploring the role of UCA
concentration ([UCA]) in bioeffect induction at 0 days post exposure (DPE) and assessing the bioeffect as a possible
potentiator of angiogenesis at 5 DPE.
Methods: A 1-MHz ultrasonic transducer was used to expose the gracilis muscles of Sprague Dawley rats for
5 min with a 10-μs pulse duration, 10-Hz pulse repetition frequency, and 0.7-MPa peak rarefactional acoustic
pressure (pr). Four [UCA]s were tested: 0x (saline), 1×, 5×, and 10×, where 1× is 5% Definity by volume of solution.
Evans blue dye (EBD) was used to quantify changes in acute vascular permeability (0 DPE), and VEGF expression
was quantified at 5 DPE to support that angiogenesis had occurred. CD31 staining was used to assess capillary
density at both time points.
Results: [UCA] was a significant parameter for determining EBD leakage (permeability) and VEGF expression
(p< 0.001 for both). However, [UCA] was not a significant parameter for capillary density at 0 or 5 DPE. Multiple
comparisons between 0 and 5 DPE showed that only 10× [UCA] at 5 DPE was significantly different than 0 DPE,
suggesting a [UCA] dependence of the angiogenic response.
Conclusions: This study suggests that [UCA] was a significant parameter in the induction of an angiogenic
response with US and UCAs. It also suggests that rather than damage from US and UCAs, as previously speculated,
a nondestructive mechanical interaction between the UCAs and vascular endothelium induces bioeffects to
potentiate the angiogenic response.
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Therapeutic ultrasoundIntroduction
There are presently three scenarios for which proangio-
genic therapies are used clinically: chronic wounds, periph-
eral arterial disease and ischemic heart disease [1,2], where
the treatment goal is to promote healing by inducing neo-
vascularization. The main drawbacks for current drug, sur-
gical, and cell-based therapies are the diffuse spread of
growth factors, invasiveness, or the inability to provide
spatially specific treatment. Ultrasound (US) and* Correspondence: wdo@uiuc.edu
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distribution, and reproduction in any mediumultrasound contrast agents (UCAs) have been shown to
provide noninvasive and spatially specific treatment, result-
ing in an angiogenic response to exposure [3].
Several studies report a reparative response to US and
UCA exposure [4-9]. While there is a body of literature
that seems to show efficacy, there is a great deal of con-
flicting results, perhaps because there is a lack of under-
standing the operative mechanisms. Recent work has
shown that UCAs affect the angiogenic response by in-
creasing expressed vascular endothelial growth factor
(VEGF) [10]. In that study, however, the difference be-
tween the controls and exposed groups were significant,
but subtle, possibly due to the relatively low UCA concen-
tration ([UCA]). Current diagnostic recommendations forCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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used in therapeutic studies, with a wide range of [UCAs]
represented in the literature [11-14].
A major impediment for progress to clinical applicabil-
ity is the lack of understanding of the mechanisms that
connect US and UCA to the angiogenesis response, and
bioeffects to subsequent angiogenesis. [UCA] is of par-
ticular interest because increasing the [UCA] increases
the number of potential cavitating bodies and the oppor-
tunity for increased bubble-bubble and bubble-vascular
interactions. Many studies imply that the mechanism of
US-UCA induced therapeutic effects occur via second-
ary wound healing; where minor, focal damage boosts
normal wound healing and promotes growth of blood
vessels into an ischemic area [13,15,16]. Recent work
suggests otherwise, however. This study seeks to explore
[UCA] in the context of bioeffect induction and subse-
quent angiogenic responses in an effort to establish a
trail of evidence that supports that US-UCA induces
bioeffects to cause angiogenesis. In addition, this study
explores the role of [UCA] on those phenomena. It is
hypothesized that increasing [UCA] will increase bioef-
fects, leading to an increased angiogenic response
through a purely mechanical mechanism.
Materials and methods
Ultrasound exposimetry
A 1-MHz focused (f/3) single-element ultrasonic trans-
ducer (Valpey Fisher E1051, 0.75” diameter; Hopkinton,
MA) connected to a power source (RAM5000, Ritec,
Inc., Warwick, RI) was used for the US exposures. An
established procedure for exposures was previously
detailed [3]. Briefly, a custom built system containing
35°C degassed water provided coupling between the
transducer and skin. An automated procedure, based on
established standards [17,18], was used to routinely cali-
brate the US fields [19,20]. The −6-dB beamwidth and
−6-dB depth of focus was measured to be 4.6 mm and
96 mm, respectively.
The in situ peak rarefactional pressures were estimated
from pr (in situ) = pr (in vitro) e
-Ax, where pr (in vitro) is
the global-maximum water-based value, and A is the at-
tenuation of intervening layers. Prior to US exposure,
the site to be exposed was measured to be equidistant
(5 mm) from the inferior and superior borders of the
gracilis muscle and approximately 7 mm from the distal
insertion of the muscle on the tibia with an externally
rotated outstretched hind limb. This site was marked
and the US transducer was visually aligned with that
marking. For focal depth alignment, a pulse-echo tech-
nique (low pr value of 50 kPa) was used to position the
focus at the surface of the muscle. After US exposure at
one site, the transducer was realigned with the next US
exposure site. US exposure conditions at each site were:pr of 0.7 MPa (attenuation of US by 1 mm of skin is neg-
ligible [21]), pulse duration of 10 cycles (10 μs), pulse
repetition frequency of 10 Hz, and exposure duration of
5 min.Animals
Twenty-eight female Sprague Dawley rats (Harlan, In-
dianapolis, IN, USA) were used to examine the role of
[UCA] in the angiogenic response. Animals ranged in
age from 11 to 13 weeks old and weighed between 190
and 215 g.
Rats were anesthetized with ketamine hydrochloride
(87 mg/kg) and xylazine (13 mg/kg) administered intra-
peritoneally. Hind limb hair covering the gracilis muscles
was removed with an electric clipper, followed by a de-
pilatory agent (NairW Carter-Wallace, Inc., New York,
NY, USA) to maximize sound transmission. The rat was
then placed in a custom built holder. Bilateral sites on
the lateral sides of the left and right gracilis muscle were
marked with a black dot to denote the US exposure lo-
cation. Medial sections of the same gracilis muscle
served as the control; that region was not exposed to
US.
The rats were divided into two groups based on days
post exposure (DPE, 0 or 5 days). For each DPE group,
the rats were further divided into four [UCA]s: (0x (sa-
line), 1×, 5×, and 10×). At 0 DPE there were four rats
per [UCA]; at 5 DPE there were three rats per [UCA]
(total of 28 rats). The manufacturer’s recommended dos-
age for infusion was used to establish the 1× concentra-
tion of Definity (Bristol-Myers Squibb Medical Imaging,
North Billerica, MA, USA). The package insert states
‘1.3 mL Definity in 50 mL saline’ should be used for in-
fusion. This [UCA] approximates to 5% Definity by vol-
ume of solution.
For 0 DPE rats, 1.5 mL of the infusion solution
(containing 0, 0.07, 0.25, or 0.75 mL Definity brought
to a volume with saline, for the 0×, 1×, 5×, and 10×
[UCA] concentrations, respectively) was prepared in a
3-mL syringe. Evans blue dye (EBD, 10 mg/mL) was
dissolved in the volume of saline prior to addition of
UCA [22]. For the 5 DPE rats, the same procedure
was followed without the addition of EBD due to pos-
sible dye toxicity and interference with the angiogenic
progression [23].
The experimental protocol was approved by the Insti-
tutional Animal Care and Use Committee of the Univer-
sity of Illinois and satisfied all campus and National
Institutes of Health rules for the humane use of labora-
tory animals. Animals were housed in an Association for
Assessment and Accreditation of Laboratory Animal
Care (Rockville, MD)-approved animal facility and pro-
vided food and water ad libitum.
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Prior to delivery of the infusion solution by the infusion
pump, the rat tail vein was manually injected for approxi-
mately 30 s with 0.5 mL of infusion solution (at 0×, 1×,
5×, or 10× [UCA]) to introduce UCAs into the circulatory
system. Then, an infusion pump (model 780100; KD Sci-
entific, Holliston, MA, USA) was used to deliver 1.0 mL
of the infusion solution over 15 min into the rat tail vein
at a rate of 4.0 mL/h with an approach previously used
[10]. The resulting maximum infusion rates with UCAs
were 3.1 × 107, 1.1 × 108, and 3.3 × 108 microbubbles/min
for 1×, 5×, and 10× [UCA], respectively.
The [UCA] was mathematically modeled to account
for the UCAs half-life (estimated to be ~0.7 min in the
rat), in vivo dissolution of Definity, duration of US ex-
posure, accumulated UCA in the syringe, and UCAs
destroyed by US exposure. The initial 30 s injection
brought the [UCA] to approximately the steady-state
[UCA] derived from infusion (the first and second
exposed sites received equivalent [UCA]). This model
assumed the recirculation rate was equal to disintegra-
tion of UCAs. The cannula was primed such that when
the pump was started, UCAs entered the circulatory sys-
tem. US exposure was initiated at site one approximately
5 s after the infusion pump was started (5-min US ex-
posure per site, 3 min for realignment with the next site,
and 2 sites per rat = 13 min). The 5-min each bilateral
US exposures were completed while the infusion pump
was still providing infusion solution. The 0x [UCA]
infused rats received the same treatment but without
UCA.
Euthanization
The 0 DPE rats were euthanized within 1 h following US
exposure. The 5 DPE rats were euthanized approxi-
mately 120 h after US exposure. Rats were euthanized
using CO2 followed by cervical dislocation with prompt
removal of US exposed muscle tissue via a 6-mm biopsy
punch. The biopsy punch size was selected such that the
entire US exposed area could be excised and the edges
would not be lost in extraction. The biopsy was obtained
from the same site as exposed, equidistant from the su-
perior and inferior borders of the gracilis muscle with an
externally rotated, outstretched limb.
Tissue preparation and processing
Because the US focus’ -6-dB beamwidth was sufficiently
large (4.6 mm), one-half of each exposed and control loca-
tion was either preserved in RNAlater (Quiagen, Valencia,
CA, USA) (for the 5 DPE rats) or soaked in formamide for
24 h (for the 0 DPE rats). The other half was fixed for
24 h in 10% PBS formalin (Fischer Scientific, USA) for
histological staining. The formalin-fixed tissues were par-
affin embedded (Thermo Fisher Scientific, USA). Three-micrometer-thick sections were stained with hematoxylin
and eosin (H&E) for tissue damage assessment, and with
CD31 antibody (CD31, Cell Marque #1A10, Rocklin, CA,
USA) for capillary density counts.
Capillary density assessment
The biopsied muscle was stained with CD31 antibodies
and used for capillary density counting using established
techniques [3,10]. Only full-lumen capillaries were
counted. The Carl ZeissW Axioscope 2 upright light
microscope was used for capillary density assessments
(Carl Zeiss Microscopy, Thornwood, NY, USA); it had a
high-power field (HPF) of 0.45 mm in diameter at 40x
magnification. Fifteen HPFs were averaged and reported
as capillaries/mm2± standard error of the mean (SEM).
These values were normalized to the medial-site control
capillary density, where a value of unity indicates equiva-
lence to the control.
Evans blue dye assessment for permeability
To quantify extravasated EBD, following US exposure,
the skin overlaying the muscle was trimmed away and a
biopsy punch was used to remove muscle from the
exposed and control sites. The biopsy punch sample was
placed on a paper towel for approximately 1 min to re-
move excess moisture and weighed; excess moisture was
removed as to not bias the recorded weight of the tissue
that used for EBD leakage quantification. Then half of
the exposed and control sites were placed in 100% for-
mamide for 24 h at 60°C. Formamide extraction allowed
the dye to come to equilibrium with the solution. The
supernatant’s absorption was measured using the Nano-
dropW 2000 spectrophotometer (Thermo Scientific,
Wimington, DE, USA) at 620 nm and the amount of dye
determined from a calibrated standard curve [20]. The
weight of the extracted tissue was recorded such that
extravasated EBD could be normalized to the tissue
weight (expressed as μg of EBD leaked per g of muscle).
These values were then normalized to the medial-site
control EBD leakage and reported as unitless values.
Vascular endothelial growth factor (VEGF) analysis
RNAlater preserved the RNA in the tissue for VEGF
analysis. First, total RNA was isolated using the
QuiagenW RNeasy kit (Quiagen, Valencia, CA, USA)
via a standard protocol [24]. Then the optical density
of the solution was determined using the NanodropW
2000 Spectrophotometer. The RNA was labeled and
stored at −80°C. After isolation, the RNA was reverse
transcribed to cDNA.
The real-time PCR was run on the cDNA with the
ABI Prism 7500 (ABI, Applied Biosytems, Foster City,
CA, USA) using a TaqMan One-Step RT-PCR Master
Mix Reagents Kit (ABI) according to the manufacturer's
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endothelial growth factor-A (VEGF) were used for the
real-time reactions. 18 S is ubiquitously expressed across
tissues and treatments, thus serves as an ideal internal
control for real-time PCR. 18 S was used as a house-
keeping gene whose stable expression allows relative
quantification of other gene expressions. The VEGF pri-
mer was designed with the forward sequence: CCACTT
CATGGGCTTTCTGCT, and reverse sequence: CACTT
GTACCTCCACCATGCCAAG. VEGF expression was
normalized to (quantified with respect to) 18 S in each
sample and data were expressed relative to normalized
values for the control in terms of fold change.Statistical analysis
One-way analysis of variance (ANOVA) in MatlabW
(The MathWorks Inc., Natick, MA, USA) was used to
determine if [UCA] were a significant parameter for
EBD, VEGF expression, and capillary density. The level
of significance was set at α= 0.05. Tukey-HSD multiple
comparisons were used to compare different combina-
tions of the concentrations to each other. Two-way
ANOVA was used to compare the 0 DPE and 5 DPE ca-
pillary densities (excluding the control). Further, mul-
tiple comparisons between the 0 DPE and 5 DPE were
performed.Results
Immunohistochemistry: capillary density (CD-31)
Capillary density was normalized to the medial-site con-
trol value. Two-way ANOVA determined that DPE was
not a significant parameter for capillary density (p> 0.05);
however, significance was found for [UCA] (p < 0.05), sug-
gesting a change in capillary density with increased [UCA]
(Figure 1). The interaction term DPE X [UCA] was not
significant (p> 0.05). Multiple comparisons between 0 andFigure 1 Normalized capillary density at 0 (light grey) and 5
(dark grey) DPE. * p< 0.05 with respect to 0 DPE at 10x [UCA]. The
medial-site control value at 0 DPE and 5 DPE was 117.31 and 139.10
capillaries/mm2, respectively; these numbers were used for
normalization.5 DPE found the capillary density to be significantly differ-
ent at 10x [UCA] (p < 0.05).
Histological assessment (H&E and CD-31)
Tissue-level effects for 0 DPE demonstrated signs of
possible capillary engorgement at 10x [UCA]. No tissue
damage, inflammatory infiltrate or necrosis was observed
at any of the UCA concentrations (Figure 2).
Evans blue dye (vascular permeability)
EBD leakage as a measurement of vascular permeability
was also normalized to the medial-site control. One-way
ANOVA was used to determine that [UCA] was a signifi-
cant parameter for EBD leakage (p< 0.001) (Figure 3). The
medial-site control samples were not significantly different
from the saline-infused (0x [UCA]) rats (p > 0.05). EBD
leakage demonstrated an increasing trend of permeability
as the [UCA] increased, with 1x [UCA] and 5× [UCA]
being near the control value for the assessment (Figure 3).
Multiple comparisons between UCA concentrations
determined that 1×, 5× and 10× [UCA] were significantly
different from 0x [UCA] (p< 0.05). 10× [UCA] was signifi-
cantly different from 1× and 5× [UCA] (p< 0.05).
Vascular endothelial growth factor-A (VEGF)
To supplement capillary density, VEGF expression was
measured to assess the angiogenic response. One-way
ANOVA was used to determine that [UCA] was a sig-
nificant parameter for VEGF expression (p < 0.001).
Lower [UCA]s showed less than half the VEGF expres-
sion than seen at 10x [UCA] (Figure 4). Multiple com-
parisons between [UCA]s indicated that 1×, 5× and 10×
[UCA] were significantly different from 0x [UCA]
(p < 0.05). 10x [UCA] was also significantly different
from 1× and 5× [UCA] (p < 0.05).
Discussion
The motivation for this study was to improve the under-
standing of US and UCA induced angiogenesis in an ef-
fort to transition the therapy to clinical use. The specific
objective of this study was to determine the effect, if
any, of [UCA] on the angiogenic response induced by
US and UCA. Further, this study examined the acute
bioeffects in an effort to provide mechanistic clues to
the angiogenic response. US exposure parameters were
chosen to reduce the thermal effects, with an estimated
maximal temperature increase of 0.5°C [25], assuming
no heat removal, which is not necessarily the case for a
5-min exposure duration. This study showed that [UCA]
was a significant parameter for determining vascular
permeability and VEGF expression (p < 0.001 for both).
Multiple comparisons between 0 and 5 DPE showed that
only 10x [UCA] at 5 DPE was significantly different than
Figure 2 Acute histology (H&E—left, CD31—right) demonstrating the lack of tissue level effects associated with US-UCA exposure for
various [UCA] at 40× magnification. Top to bottom: medial-site control, saline (0x [UCA]), 1× [UCA], 5× [UCA], 10× [UCA]. Bar = 50 μm. Arrows
show capillary engorgement.
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Figure 3 Normalized EBD extravasation indicating vascular
permeability at varying [UCA]. * p< 0.05 with respect to 0x [UCA],
+ p< 0.05 with respect to 1x. The medial-site control for EBD
leakage was 8.84 μg of dye/g of muscle.
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Working with the hypothesis that increased [UCA]
leads to increased bioeffects (without tissue-level dam-
age) and an increased angiogenic response, the serial as-
sessment of bioeffects and angiogenic response was
carried out at several [UCA]s. In US-induced angiogenic
therapy, UCA concentrations typically have exceeded the
standard recommendations for imaging [4,13,26]. US
and UCA therapy use [UCA]s ranging from 0 to 60%
UCA by volume of solution [4,9,12-14], and the litera-
ture reports a variety of effective [UCA]s.Variability in
the dosages (some [UCA]s are not reported) and differing
delivery methods (i.e., bolus or infusion) make it difficult
to extrapolate the results to new applications [5,9,12,27].
The [UCA] range chosen herein was scaled to ensure ani-
mal survival. One study found that mouse death occurred
at a concentration of 7.5 ×107 microbubbles injected over
3 min [4] which equates to 3.3×109 microbubbles/min
(relative to the 3.3×108 microbubbles/min maximum
[UCA] used in this study); this information was used to de-
termine the upper [UCA] limit. High [UCA] may also causeFigure 4 Normalized VEGF expression (in fold change) at
various [UCA]s. * p< 0.05 with respect to 0x [UCA], + p< 0.05 with
respect to 1×, 5× [UCA].excess bioeffects to occur. ‘Excess bioeffects’ is defined here
as a reduction in acute (0 DPE) capillary density or tissue-
level changes (hemorrhage, inflammation or necrosis). One
study showed that an estimated dosage of 3.2 ×1010 micro-
bubbles/min (an equivalent of 16x [UCA] with the para-
meters used in this study) injured rat cardiomyocytes;
recovery from injury was not explored [28]. Another study
demonstrated an increase in capillary rupture with increas-
ing [UCA], but after a ‘sufficiently’ high dose of UCAs was
used in mice, increasing that dose did not change the re-
sponse [4]. Therefore this study addressed a range of
[UCA]s were explored in this study. The next step was to
evaluate how [UCA] affected the acute bioeffects.
To study the bioeffects of US, EBD is frequently used.
Research has shown that exposure to US and UCAs
cause vessel leakage [9,25,29-31]. Microvascular effects
have been shown to increase with increasing UCA dos-
age [27], which agrees with the findings herein (Figure 3).
While UCAs were not visualized in vivo, the UCAs
range of dynamic motions from oscillation at low pr to
inertial cavitation at sufficiently high pr has been charac-
terized in vitro [32,33]. Previous studies demonstrate
that at the pr used herein, the predominant UCA effect
is oscillation [32,33]. Presumably, it is the hemodynamic
changes induced by the UCA oscillation that perturbs
the vascular endothelium leading to bioeffects. It has
been speculated that US and UCAs increase vascular
permeability by destabilizing the tight junctions asso-
ciated with blood vessels, showing increased permeabil-
ity up to 9 h after exposure [31]. Focused US, along with
lipid shelled UCAs has been shown to increase EBD ex-
travasation in muscle with as much as 8% of the total
injected dose leaking at the exposed site [9]. In agree-
ment with the literature and proposed hypothesis,
increased [UCA] was associated with increased EBD ex-
travasation (permeability bioeffect). Once permeability
was assessed, the next step was to determine whether an
angiogenic response occurred. VEGF and capillary dens-
ity were used to assess angiogenesis.
VEGF, like US application, is known to play a role in in-
creasing vascular permeability, therefore increases may be
detected in as little as 1 h [10], which suggests that perme-
ability could have remained elevated from the time of ex-
posure until the angiogenic response was assessed. Shay-
Salit et al. [34] found that VEGF receptors could be acti-
vated in approximately 2 min in bovine aortic endothelial
cells exposed to shear stress or VEGF-A. US and UCAs
could directly (acutely) increase VEGF or indirectly in-
crease VEGF via shear stress from UCA oscillations that
elicit permeability changes.
VEGF is necessary throughout the angiogenic process
involving vascular endothelial cell migration and mitosis,
and apoptosis inhibition. So, while acute increases may
occur, VEGF typically peaks 3 to 7 days after insult in
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VEGF at 5 DPE that correlated well with the increases in
vascular permeability, displaying similar overall trends. To
support VEGF expression and permeability assessments,
capillary density was assessed at 0 and 5 DPE.
The 0 DPE capillary density did not significantly change
with [UCA] (Figure 1), nor were there any biologically sig-
nificant signs of hemorrhage, inflammation, or necrosis
after exposure (Figure 2). These observations suggest that
the increased vascular permeability was the result of US
and UCA mechanical interactions with the vasculature
causing increased porosity or increased size of pores be-
tween endothelial cells. While locally circulating cells may
be damaged, the vessel lumen remains intact as demon-
strated by capillary density assessments at 0 DPE (Figure 1).
Capillary density assessed at 5 DPE showed a signifi-
cant difference with respect to 0 DPE for the 10x [UCA]
(Figure 1), supporting the notion that sufficient increases
in permeability could motivate an angiogenic response.
There was no significant difference with 0x [UCA], 1×
[UCA], or 5× [UCA] with multiple comparisons. This
lack of significant difference (between 0 and 5 DPE) may
be because the disturbance caused with lower concentra-
tions was sufficient to statistically increase extravasation
and VEGF, but not enough to biologically motivate an
angiogenic response. Alternatively, the responses oc-
curred before or after the 5 DPE time point assessment.
Previous studies assessed 3 and 6 DPE time points and
do not support the latter statement, however [10].
There appears to be a threshold dependence on
[UCA] for the production of bioeffects, with permeabil-
ity increasing from baseline at 1x [UCA]. VEGF expres-
sion was detected at 1x [UCA] as well, but the threshold
was higher for the angiogenic response to be detected
with capillary density (at 10x [UCA]). These findings
suggest that, again while lower UCA concentrations may
motivate a statistically significant response, it may be in-
sufficient to cause angiogenesis.
Conclusions
[UCA] demonstrates a significant effect not only in the
acute bioeffects, but also in the subsequent angiogenic
response. The response for both acute bioeffects and
angiogenic response are positively correlated with the
infused [UCA]. Beginning with a suggested mechanically
induced increase in permeability, an increase in capillary
density and a 3 fold change in VEGF was found. These
experiments support the view that US and UCA expos-
ure causes a mechanical effect, without tissue damage,
that leads to increased microvascular permeability which
induces vascular remodeling resulting in angiogenesis.
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